Stiolto copay card 2026?

See the DrugPatentWatch profile for Stiolto

Stiolto Respimat Copay Card Availability

Information regarding the specific availability of a Stiolto Respimat copay card for the year 2026 is not yet publicly disclosed [1]. Copay assistance programs are typically updated annually.

What is Stiolto Respimat?

Stiolto Respimat is a prescription medication used for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) [2]. It combines two bronchodilators: tiotropium, an anticholinergic, and olodaterol, a long-acting beta2-adrenergic agonist (LABA) [2].

How Do Copay Cards Work for Stiolto Respimat?

Copay cards, often provided by the manufacturer or through patient assistance programs, help reduce the out-of-pocket cost for eligible patients prescribed a medication like Stiolto Respimat [1][3]. These cards typically cover a portion of the prescription cost, lowering the patient's copayment to a specified amount. Eligibility criteria, such as insurance status and residency, often apply [3].

When Can I Expect Updates on 2026 Stiolto Respimat Programs?

Manufacturers typically announce updates to their patient assistance and copay programs, including those for Stiolto Respimat, towards the end of the current year or at the beginning of the following year [1]. Patients and healthcare providers should monitor the official Stiolto Respimat website or contact the manufacturer's patient support services for the most current information.

Where Can I Find Stiolto Respimat Patient Assistance Information?

Information on Stiolto Respimat patient assistance programs, including copay cards, can usually be found on the official Stiolto Respimat website. Boehringer Ingelheim, the manufacturer, offers resources for patients seeking support with medication costs [3].

Sources

[1] DrugPatentWatch.com
[2] Stiolto Respimat official website
[3] Boehringer Ingelheim patient support